COMBOGESIC

PeakSM

acetaminophen and ibuprofen

NDAORALTABLET
Approved
Mar 2023
Lifecycle
Peak
Competitive Pressure
0/100

Mechanism of Action

Cyclooxygenase Inhibitors

Pharmacologic Class:

Nonsteroidal Anti-inflammatory Drug

Loss of Exclusivity

LOE Date
Feb 27, 2039
158 months away
Patent Expiry
Feb 27, 2039
Exclusivity Expiry
Mar 1, 2026

Patent Records (2)

Patent #ExpiryTypeUse Code
11197830
Feb 27, 2039
Product
U-3553
11534407
Feb 27, 2039
Product
U-3553
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers